Using Virtual Reality Therapy to Help Swallowing in Wallenberg Syndrome

A Randomized Controlled Study to Explore the Effect of Virtual Reality Therapy on Dysphagia in Wallenberg Syndrome

NA · People's Hospital of Zhengzhou University · NCT06286020

This study tests if using Virtual Reality Therapy can improve swallowing for people with Wallenberg Syndrome when combined with regular treatment.

Quick facts

PhaseNA
Study typeInterventional
Enrollment80 (estimated)
Ages18 Years to 85 Years
SexAll
SponsorPeople's Hospital of Zhengzhou University (other)
Locations1 site (Xinzhu)
Trial IDNCT06286020 on ClinicalTrials.gov

What this trial studies

This clinical trial investigates the effectiveness of Virtual Reality Therapy in treating dysphagia, a swallowing disorder, in patients with Wallenberg Syndrome. Participants will receive both conventional dysphagia treatment and Virtual Reality Therapy daily for 14 days. The study aims to compare the outcomes of these patients with a control group to assess the impact and mechanisms of Virtual Reality Therapy on swallowing rehabilitation.

Who should consider this trial

Good fit: Ideal candidates are right-handed adults aged 18-85 with confirmed dysphagia due to Wallenberg Syndrome.

Not a fit: Patients with pre-existing dysphagia from other conditions, such as Parkinson's disease or dementia, may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could significantly improve swallowing function and quality of life for patients with Wallenberg Syndrome.

How similar studies have performed: While the application of Virtual Reality in rehabilitation is promising, this specific approach for dysphagia in Wallenberg Syndrome is relatively novel and has not been extensively tested.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age ranged from 18-85 years and right-handed;
* first onset, vital signs stable and conscious;
* the dysphagia confirmed by videofluoroscopic swallowing study;
* no cognitive impairment, the mini-mental state examination score: \>17 for those with an illiterate education, \>20 for those with an elementary education, and \>24 for those with a secondary education and above;
* cranial integrity without craniotomy and/or craniectomy;
* patient and/or his/her relative agrees and signs written informed consent.

Exclusion Criteria:

* combined ischemic foci at other sites;
* presence of organic swallowing dysfunction or pre-existing dysphagia due to Parkinson's disease, dementia, and others;
* severe cardiac, pulmonary, hepatic, and renal insufficiency and vital organ failure;
* infected or broken skin on the head;
* poorly controlled epilepsy;
* poor patient compliance.

Where this trial is running

Xinzhu

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Wallenberg Syndrome

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.